-
EP1261606
European procedure
Extract from the Register of European Patents
EP About this file: EP1261606
| EP1261606 - SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 30.12.2005 Database last updated on 25.12.2024 | Most recent event Tooltip | 30.12.2005 | No opposition filed within time limit | published on 15.02.2006 [2006/07] | Applicant(s) | For all designated states Bayer HealthCare AG 51368 Leverkusen / DE | [2004/01] |
| Former [2002/49] | For all designated states Bayer Aktiengesellschaft 51368 Leverkusen / DE | Inventor(s) | 01 /
STRAUB, Alexander Moospfad 30 42113 Wuppertal / DE | 02 /
LAMPE, Thomas Briller Strasse 46 42105 Wuppertal / DE | 03 /
POHLMANN, Jens Kronenstrasse 14 42285 Wuppertal / DE | 04 /
RÖHRIG, Susanne Buschstrasse 20 45276 Essen / DE | 05 /
PERZBORN, Elisabeth Am Tescher Busch 13 42327 Wuppertal / DE | 06 /
SCHLEMMER, Karl-Heinz Wildsteig 22a 42113 Wuppertal / DE | 07 /
PERNERSTORFER, Joseph Alsenstrasse 19 42109 Wuppertal / DE | [2002/49] | Application number, filing date | 00993610.5 | 11.12.2000 | [2002/49] | WO2000EP12492 | Priority number, date | DE1999162924 | 24.12.1999 Original published format: DE 19962924 | [2002/49] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO0147919 | Date: | 05.07.2001 | Language: | DE | [2001/27] | Type: | A1 Application with search report | No.: | EP1261606 | Date: | 04.12.2002 | Language: | DE | The application published by WIPO in one of the EPO official languages on 05.07.2001 takes the place of the publication of the European patent application. | [2002/49] | Type: | B1 Patent specification | No.: | EP1261606 | Date: | 23.02.2005 | Language: | DE | [2005/08] | Search report(s) | International search report - published on: | EP | 05.07.2001 | Classification | IPC: | C07D413/14, C07D413/12, C07D417/14, A61K31/42, A61P7/00 | [2002/49] | CPC: |
C07D498/04 (EP,KR,US);
A61K31/5377 (EP,KR,US);
A61P19/02 (EP);
A61P25/28 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P7/04 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07D333/38 (EP,KR,US);
C07D409/12 (EP,KR,US);
C07D413/10 (EP,KR,US);
C07D413/12 (EP,KR,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/49] | Extension states | AL | Not yet paid | LT | 24.07.2002 | LV | 24.07.2002 | MK | 24.07.2002 | RO | 24.07.2002 | SI | 24.07.2002 | Title | German: | SUBSTITUIERTE OXAZOLIDINONE UND IHRE VERWENDUNG IM GEBIET DER BLUTGERINNUNG | [2002/49] | English: | SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION | [2002/49] | French: | OXAZOLIDINONES SUBSTITUEES ET LEUR UTILISATION DANS LE DOMAINE DE LA COAGULATION SANGUINE | [2002/49] | Entry into regional phase | 24.07.2002 | National basic fee paid | 24.07.2002 | Designation fee(s) paid | 24.07.2002 | Examination fee paid | Examination procedure | 18.06.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 24.07.2002 | Examination requested [2002/49] | 20.08.2003 | Despatch of a communication from the examining division (Time limit: M08) | 23.04.2004 | Reply to a communication from the examining division | 07.06.2004 | Communication of intention to grant the patent | 17.12.2004 | Fee for grant paid | 17.12.2004 | Fee for publishing/printing paid | Divisional application(s) | EP04027037.3 / EP1526132 | Opposition(s) | 24.11.2005 | No opposition filed within time limit [2006/07] | Fees paid | Renewal fee | 02.01.2003 | Renewal fee patent year 03 | 02.01.2004 | Renewal fee patent year 04 | 03.01.2005 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]EP0645376 (MERCK PATENT GMBH [DE]) [A] 1-15* example -; claim 1 *; | [DX]WO9931092 (MERCK PATENT GMBH [DE], et al) [DX] 1-15 * claim - * *Beispiel 1: Seite 37, Zeilen 29-31; Seite 40, Zeilen 30-31* *Beispiel 2: Seite 45, Zeilen 34-36; Seite 48, Zeilen 8-9* *Beispiel 5: Seite 54, Zeilen 30-32; Seite 56, Zeilen 9-11*; | [A] - BECKER M R ET AL, "Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,GB,OXFORD, (19990920), vol. 9, no. 18, ISSN 0960-894X, pages 2753 - 2758, XP004179965 [A] 1-15 * figure 1 * DOI: http://dx.doi.org/10.1016/S0960-894X(99)00466-7 |